Home Johnson & Johnson Showcases Social Impact Initiatives at CIIE Under the Theme 'Guided by Our Credo, Giving Back to Society'

Johnson & Johnson Showcases Social Impact Initiatives at CIIE Under the Theme 'Guided by Our Credo, Giving Back to Society'

Nov 07, 2023 20:39 CST Updated 20:39
Johnson & Johnson

Medical Device R&D and Manufacturer

ShanghaiNovember 7, 2023PR Newswire -- During the 6th China International Import Expo, Johnson & Johnson not only showcased over a hundred groundbreaking innovative products under a refreshed brand image but also comprehensively displayed the company’s abundant achievements in improving human health and giving back to society through the "Credo-Guided Social Contributions" exhibition area. This highlighted Johnson & Johnson's mission to promote human health and build a better society, guided by the spirit of its Credo and driven by extensive influence. This year marks the 80th anniversary of Johnson & Johnson's "Our Credo," the corporate guiding principle written in 1943 that outlines the company’s responsibilities to patients, healthcare professionals, employees, the environment, and society. It has inspired generations of Johnson & Johnson employees to advance human health with determination and perseverance.

“我们的信条”指引强生砥砺前行
"Our Credo" Guides Johnson & Johnson Forward

 

第六届进博会强生展台“信条指引回馈社会”展区
"Creed Guides Giving Back to Society" Exhibition Area at Johnson & Johnson's Booth during the 6th CIIE

Accelerate the Introduction of Innovative Achievements, Support the Improvement of Access to High-Quality Medical Resources

For many years, Johnson & Johnson has continuously introduced and promoted the implementation of globally leading medical innovation product solutions in China. Currently, out of the 33 innovative pharmaceutical products that have entered the Chinese market, 30 are already included in the national medical insurance catalog, covering therapeutic areas such as oncology, immunology, infectious diseases and vaccines, neuroscience, cardiovascular and metabolic diseases, and pulmonary arterial hypertension. The innovative medical products from Johnson & Johnson Medical Technology’s surgery, orthopedics, interventional solutions, and eye health businesses continue to better and more quickly serve a wide range of patients and families in China through rapid introduction, localized production, and innovative collaborations.

Johnson & Johnson also continues to support disease awareness through charitable efforts, promoting the early diagnosis and treatment of various diseases, including highly prevalent cancers such as breast cancer, cardiovascular and cerebrovascular conditions like atrial fibrillation and stroke, immune disorders such as inflammatory bowel disease, pulmonary hypertension, depression and schizophrenia, psoriasis, and sports injuries.

Empowering Healthcare Professionals, Promoting High-Quality Development in the Medical and Health Industry

Johnson & Johnson Leverages Its Strengths to Advance Medical Continuing Education in China

In 2021, Johnson & Johnson became the first multinational company to announce the "Three Strategies and Six Initiatives" to support the government's vision of achieving common prosperity. By establishing a global community impact special fund, it has invested over 150 million RMB in total to promote the development of China’s healthcare industry, support grassroots healthcare worker training, and advance projects in key areas such as mental health, eye health, populations in urgent need of surgery, and common diseases among the elderly in communities. The goal is to help 200,000 grassroots medical workers improve their medical service capabilities by 2023.

Build a Diverse and Inclusive Corporate Culture, Promote Employer Branding and Talent Development

Johnson & Johnson has always been committed to building a people-oriented, diverse, and inclusive corporate culture. Through innovative initiatives, it continuously enhances its employer brand from multiple dimensions, achieving fruitful results in corporate culture development and talent growth.

Johnson & Johnson has internally established the "Socially Beneficial People" employee volunteer platform, while providing four days of volunteer leave annually to support and encourage employees to participate in social public welfare activities. This helps employees expand their capabilities and realize self-worth, while also offering tangible assistance to nonprofit organizations in creating social value. As of 2022, employees of Johnson & Johnson China have completed over 40,000 hours of volunteer service. Under the leadership of Johnson & Johnson China’s Diversity, Equity, and Inclusion (DE&I) Committee, Employee Resource Groups actively promote cross-departmental, cross-functional, and cross-generational exchanges on topics such as women's leadership and mental health. Additionally, Johnson & Johnson has collaborated with major universities to establish student organizations, organizing career development and public welfare activities that cultivate "future leaders" with a sense of social responsibility, outstanding leadership, and strong business acumen, receiving an enthusiastic response.

Building a Healthy Environment Together, Achieving Green and Sustainable Development

"The environment and natural resources must be well protected" is explicitly stated in Johnson & Johnson's "Our Credo." Johnson & Johnson China has made long-term investments and effective practices in multiple dimensions such as green, low-carbon, and sustainable development. Currently, the Suzhou Industrial Park, Hangzhou factory, and Guangzhou factory have all achieved 100% green electricity.

All new office buildings, factories, and laboratories constructed by Johnson & Johnson globally are designed and built according to the LEED green building certification standards of the international green building certification system. The main buildings of the Suzhou Industrial Park and the Xi'an Janssen factory have both received LEED Gold certification, while the Johnson & Johnson China headquarters building in Shanghai has obtained the highest level LEED Platinum certification, known as the "Oscar" of green buildings.

Johnson & Johnson is also committed to building a sustainable ecosystem across the entire value chain. It actively collaborates with suppliers that have sustainable development capabilities, providing services with innovative insights while encouraging upstream partners to fulfill their green commitments and corporate social responsibilities.

Practice Corporate Social Responsibility, Advance Economic and Social Progress

Guided by its credo, Johnson & Johnson has continuously invested resources in major natural disasters, public health crises, and humanitarian causes, giving back to society. Over the past six years, Johnson & Johnson has donated a total of 1.2 billion yuan for social welfare, disaster relief, patient support, and other programs.

Johnson & Johnson actively fulfills its procurement social responsibility by launching the "Global Supplier Diversity and Inclusion Program" in 1998, aiming to promote economic development while emphasizing the promotion of social equity and creating more job positions for society. In China, the program has incorporated 16 local enterprises into the diversified supplier system.

Song Weiqun, Global Senior Vice President of Johnson & Johnson and Chairman of Johnson & Johnson China, stated: "The spirit of the Credo has always been the compass guiding Johnson & Johnson's progress. With nearly 40 years of presence in China, Johnson & Johnson is committed to working with the government and various sectors of the industry to build a high-quality healthcare system through innovative healthcare products and advanced service concepts, contributing to the construction of 'Healthy China.' At the same time, we actively fulfill our corporate social responsibility and exert social influence, looking forward to continuing to collaborate with all parties to create an even better and healthier future!"